Acorda Acquires Civitas Therapeutics for $525M for Parkinson's Treatment

... in a $525 million cash deal that would provide the buyer access to a late-stage Parkinson's disease treatment. Ardsley, N.Y.-based Acorda markets three therapies focused on countering neurological disorders. Buying Civitas would give it worldwide ...

http://ift.tt/1xgtzQ0